MAYA PARIS: Open Payments
NPI 1225687957 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,840 in 143 payments from 27 companies in 2025. Trend: 2023 $2,289 · 2024 $3,450 · 2025 $2,840
Food & beverage: $2,840
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $421 |
| UCB, Inc. | 19 | $411 |
| Novartis Pharmaceuticals Corporation | 10 | $232 |
| ABBVIE INC. | 17 | $213 |
| SK Life Science, Inc. | 12 | $192 |
| Lilly USA, LLC | 7 | $153 |
| Lundbeck LLC | 9 | $143 |
| Teva Pharmaceuticals USA, Inc. | 7 | $123 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Alexion Pharmaceuticals, Inc. | 4 | $95 |
Products named: NURTEC ODT, KESIMPTA, QULIPTA, AUSTEDO XR, Zilbrysq, Fintepla, KISUNLA, Nayzilam.
Industry payments across FL — which companies pay providers there.
